Biomarkers in experimental models of antibody-mediated neuropathies

Journal of the Peripheral Nervous System

Volumn 16, Issue SUPPL. 1, 2011, Pages 60-62

  Willison, Hugh J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

animal; biomarkers; CIDP; glycolipid; model

Indexed keywords

BIOLOGICAL MARKER; GANGLIOSIDE GD 1B; MYELIN PROTEIN;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ACUTE MOTOR AXONAL NEUROPATHY; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; EXPERIMENTAL STUDY; GUILLAIN BARRE SYNDROME; HUMAN; NEUROPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 79959587028     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00310.x     Document Type: Article

References (13)

1. Halstead SK, O'Hanlon GM, Humphreys PD, Morrison DB, Morgan BP, Todd AJ, Plomp JJ, Willison HJ, (2004). Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127: 2109-2123. (Pubitemid 39150268)
2. Hays AP, Latov N, Takatsu M, Sherman WH, (1987). Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 37: 242-256. (Pubitemid 17015497)
3. Hughes RA, Allen D, Makowska A, Gregson NA, (2006). Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 11: 30-46. (Pubitemid 43344973)
4. Köller H, Kieseier BC, Jander S, Hartung HP, (2005). Chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 352: 1343-1356.
5. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I, (1996). Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39: 424-431. (Pubitemid 26117997)
6. Lonigro A, Devaux JJ, (2009). Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 132: 260-273.
7. McGonigal R, Rowan EG, Greenshields KN, Halstead SK, Humphreys PD, Rother RP, Furukawa K, Willison HJ, (2010). Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133: 1944-1960.
8. O'Hanlon GM, Humphreys PD, Goldman RS, Halstead SK, Bullens RW, Plomp JJ, Ushkaryov Y, Willison HJ, (2003). Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain 126: 2497-2509. (Pubitemid 37314438)
9. Plomp JJ, Willison HJ, (2009). Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 587: 3979-3999.
10. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N, (2007). Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27: 3956-3967. (Pubitemid 46597169)
11. Waksman H, Adams RD, (1955). Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 1102: 213-236.
12. Willison HJ, Yuki N, (2002). Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625. (Pubitemid 35423511)
13. Willison HJ, Trapp BD, Bacher JD, Dalakas MC, Griffin JW, Quarles RH, (1988). Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve 11: 1169-1176. (Pubitemid 18263155)